Multiple Manufacturers

MOZOBIL

Manufacturer:

Multiple Manufacturers

Mozobil HCPCS:

J2562

HCPCS Code Descriptor:

Injection, plerixafor, 1 mg

Category:

J Code

Mozobil NDCs:

70710-1208-01, 00480-4320-01, 72205-0249-01, 71288-0155-01, 43598-0308-23, 65219-0284-12, 70121-1694-02, 55150-0356-01, 00024-5862-01

Primary Type:

Oncology Colony Stimulating Factor

Generic/Specialty Status:

Multi-Source

Package Type:

Vial

Route of Administration:

Subcutaneous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Mozobil:

MOZOBIL is a medication manufactured by multiple manufacturers and aligned to the J Code: J2562. MOZOBIL is administered via the subcutaneous route of administration.

ACCESS PRICING AND MORE BY REGISTERING

J2562 Added Date:

January 1, 2010

J2562 Effective Date:

January 1, 2010

J2562 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Mozobil billing and coding information.
Mozobil patient assistance information can be found through Sanofi Patient Connection at the URL: http://www.sanofipatientconnection.com/
MOZOBIL prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for MOZOBIL. Please check back in a few weeks.